Shanghai Jiao Tong University School of Medicine
444
70
88
155
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
2.5%
11 terminated/withdrawn out of 444 trials
93.4%
+6.9% vs industry average
22%
96 trials in Phase 3/4
1%
2 of 155 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (444)
Circadian-Synchronized Breast Milk Feeding and Sleep in Preterm Infants: A Multicenter Randomized Controlled Trial
Role: lead
PD-1 Antibody and JAK1 Inhibitor for Newly Diagnosed Pediatric Hodgikin's Lympoma
Role: lead
Effect of PPIs on Stool DNA Test for H. Pylori
Role: lead
Early Lumbar Drainage for Intraventricular Hemorrhage
Role: collaborator
A Study of Chiglitazar in Patients With Metabolic Dysfunction-associated Steatohepatitis and Type 2 Diabetes Mellitus
Role: lead
Decreasing Risk of Psychosis by Sulforaphane (DROPS Trial)
Role: lead
Enhanced White Light Endoscopy Versus Conventional White Light Endoscopy for Colorectal Adenoma Detection: A Randomized Controlled Trial
Role: lead
Genetics of Obesity in Chinese Youngs
Role: lead
Effects of Berberine on the Human Gut Microbiome
Role: collaborator
Support System Design for Adolescent Scoliosis Orthosis Wear
Role: lead
Efficacy, Safety, and Tolerability of CS0159 Combined With Semaglutide in MAFLD Patients With Obesity and T2DM
Role: lead
Phase II Study of Sonrotoclax Combined With Chemotherapy in the Treatment of Newly Diagnosed Acute Myeloid Leukemia
Role: lead
Evaluation of Product Effectiveness of the Intervention for Patients With Knee Osteoarthritis
Role: lead
Early Myocardial Dysfunction Helps Identify Severe Refractory Pediatric Lupus
Role: lead
Aclarubicin Plus Cyclophosphamide, Vincristine, and Prednisone (CAOP) in Patients With Previously Untreated Peripheral T-Cell Lymphoma
Role: lead
Aclarubicin Plus Cyclophosphamide, Vincristine, and Prednisone (CAOP) in Patients With Previously Treated Cutaneous T-cell Lymphoma
Role: lead
Organoid-based Sensitivity-guided Chemotherapy for Advanced / Refractory Pediatric Tumors
Role: lead
Impact of CADx on Endoscopists' Histologic Characterization of Diminutive Colorectal Polyps
Role: lead
Treatment of Advanced Endocrine Tumor With Iindividualized mRNA Neoantigen Vaccine (mRNA-0523-L001)
Role: lead
Optimization of Minocycline for Helicobacter Pylori Rescue Treatment
Role: lead